Janiczek Wealth Management, LLC Moderna, Inc. Transaction History

Janiczek Wealth Management, LLC

$475 Million
Q2 2024

A detailed history of Janiczek Wealth Management, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 19 shares of MRNA stock, worth $765. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 19 -0.0%

Holding current value

$765

Previous $2,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$85.37 - $115.44 $8,537 - $11,544	-100 Reduced 84.03%	19 $2,000
Q4 2023 Jan 26, 2024	SELL	$69.51 - $104.43 $208 - $313	-3 Reduced 2.46%	119 $11,000
Q3 2023 Oct 13, 2023	BUY	$96.41 - $126.61 $7,809 - $10,255	81 Added 197.56%	122 $12,000
Q2 2023 Jul 11, 2023	SELL	$118.5 - $160.53 $1,185 - $1,605	-10 Reduced 19.61%	41 $4,000
Q1 2023 Apr 21, 2023	SELL	$135.66 - $197.02 $3,934 - $5,713	-29 Reduced 36.25%	51 $7,000
Q4 2022 Jan 20, 2023	BUY	$118.38 - $210.04 $1,538 - $2,730	13 Added 19.4%	80 $0
Q3 2022 Oct 17, 2022	SELL	$118.07 - $194.18 $5,313 - $8,738	-45 Reduced 40.18%	67 $8,000
Q2 2022 Aug 03, 2022	SELL	$117.13 - $176.59 $2,342 - $3,531	-20 Reduced 15.15%	112 $18,000
Q1 2022 May 05, 2022	SELL	$126.46 - $235.05 $15,933 - $29,616	-126 Reduced 48.84%	132 $23,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $9,258 - $15,108	41 Added 18.89%	258 $66,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $19,527 - $42,633	88 Added 68.22%	217 $84,000
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $2,987 - $5,404	23 Added 21.7%	129 $30,000
Q1 2021 Apr 28, 2021	BUY	$109.18 - $185.98 $1,637 - $2,789	15 Added 16.48%	106 $14,000
Q4 2020 Jan 26, 2021	BUY	$65.74 - $169.86 $5,061 - $13,079	77 Added 550.0%	91 $10,000
Q3 2020 Oct 19, 2020	BUY	$54.34 - $94.85 $760 - $1,327	14 New	14 $1,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.

Account

Janiczek Wealth Management, LLC Moderna, Inc. Transaction History